340 related articles for article (PubMed ID: 1354782)
1. Primary pancreatic beta-cell secretory defect caused by mutations in glucokinase gene in kindreds of maturity onset diabetes of the young.
Velho G; Froguel P; Clement K; Pueyo ME; Rakotoambinina B; Zouali H; Passa P; Cohen D; Robert JJ
Lancet; 1992 Aug; 340(8817):444-8. PubMed ID: 1354782
[TBL] [Abstract][Full Text] [Related]
2. High prevalence of glucokinase mutations in Italian children with MODY. Influence on glucose tolerance, first-phase insulin response, insulin sensitivity and BMI.
Massa O; Meschi F; Cuesta-Munoz A; Caumo A; Cerutti F; Toni S; Cherubini V; Guazzarotti L; Sulli N; Matschinsky FM; Lorini R; Iafusco D; Barbetti F;
Diabetologia; 2001 Jul; 44(7):898-905. PubMed ID: 11508276
[TBL] [Abstract][Full Text] [Related]
3. Specific insulin and proinsulin secretion in glucokinase-deficient individuals.
Pardini VC; Velho G; Reis R; Purisch S; Blanché H; Vieira JG; Moisés RC
Braz J Med Biol Res; 1999 Apr; 32(4):427-30. PubMed ID: 10347805
[TBL] [Abstract][Full Text] [Related]
4. beta-cell genes and diabetes: quantitative and qualitative differences in the pathophysiology of hepatic nuclear factor-1alpha and glucokinase mutations.
Pearson ER; Velho G; Clark P; Stride A; Shepherd M; Frayling TM; Bulman MP; Ellard S; Froguel P; Hattersley AT
Diabetes; 2001 Feb; 50 Suppl 1():S101-7. PubMed ID: 11272165
[TBL] [Abstract][Full Text] [Related]
5. Lilly Lecture 1994. The beta-cell in diabetes: from molecular genetics to clinical research.
Polonsky KS
Diabetes; 1995 Jun; 44(6):705-17. PubMed ID: 7789637
[TBL] [Abstract][Full Text] [Related]
6. Diabetes complications in NIDDM kindreds linked to the MODY3 locus on chromosome 12q.
Velho G; Vaxillaire M; Boccio V; Charpentier G; Froguel P
Diabetes Care; 1996 Sep; 19(9):915-9. PubMed ID: 8875082
[TBL] [Abstract][Full Text] [Related]
7. Familial hyperglycemia due to mutations in glucokinase. Definition of a subtype of diabetes mellitus.
Froguel P; Zouali H; Vionnet N; Velho G; Vaxillaire M; Sun F; Lesage S; Stoffel M; Takeda J; Passa P
N Engl J Med; 1993 Mar; 328(10):697-702. PubMed ID: 8433729
[TBL] [Abstract][Full Text] [Related]
8. Insulin secretion and insulin sensitivity in diabetic subgroups: studies in the prediabetic and diabetic state.
Tripathy D; Carlsson AL; Lehto M; Isomaa B; Tuomi T; Groop L
Diabetologia; 2000 Dec; 43(12):1476-83. PubMed ID: 11151756
[TBL] [Abstract][Full Text] [Related]
9. Maturity onset diabetes of the young (MODY).
Fajans SS; Bell GI; Bowden DW; Halter JB; Polonsky KS
Diabet Med; 1996 Sep; 13(9 Suppl 6):S90-5. PubMed ID: 8894490
[TBL] [Abstract][Full Text] [Related]
10. Caudal regression syndrome in a fetus of a glucokinase-maturity-onset diabetes of the young pregnancy.
Taylor RAM; Mackie A; Mogra R; Pinner J; Rajendran S; Ross GP
Diabet Med; 2019 Feb; 36(2):252-255. PubMed ID: 30362177
[TBL] [Abstract][Full Text] [Related]
11. Insulin secretory abnormalities in subjects with hyperglycemia due to glucokinase mutations.
Byrne MM; Sturis J; Clément K; Vionnet N; Pueyo ME; Stoffel M; Takeda J; Passa P; Cohen D; Bell GI
J Clin Invest; 1994 Mar; 93(3):1120-30. PubMed ID: 8132752
[TBL] [Abstract][Full Text] [Related]
12. Incretin hormones and maturity onset diabetes of the young--pathophysiological implications and anti-diabetic treatment potential.
Østoft SH
Dan Med J; 2015 Sep; 62(9):. PubMed ID: 26324089
[TBL] [Abstract][Full Text] [Related]
13. Assessment of insulin sensitivity in glucokinase-deficient subjects.
Clément K; Pueyo ME; Vaxillaire M; Rakotoambinina B; Thuillier F; Passa P; Froguel P; Robert JJ; Velho G
Diabetologia; 1996 Jan; 39(1):82-90. PubMed ID: 8720607
[TBL] [Abstract][Full Text] [Related]
14. Dorzagliatin, a Dual-Acting Glucokinase Activator, Increases Insulin Secretion and Glucose Sensitivity in Glucokinase Maturity-Onset Diabetes of the Young and Recent-Onset Type 2 Diabetes.
Chow E; Wang K; Lim CKP; Tsoi STF; Fan B; Poon E; Luk AOY; Ma RCW; Ferrannini E; Mari A; Chen L; Chan JCN
Diabetes; 2023 Feb; 72(2):299-308. PubMed ID: 36342518
[TBL] [Abstract][Full Text] [Related]
15. Counterregulatory responses to hypoglycemia in patients with glucokinase gene mutations.
Guenat E; Seematter G; Philippe J; Temler E; Jequier E; Tappy L
Diabetes Metab; 2000 Nov; 26(5):377-84. PubMed ID: 11119017
[TBL] [Abstract][Full Text] [Related]
16. Abnormal regulation of hepatic glucose output in maturity-onset diabetes of the young caused by a specific mutation of the glucokinase gene.
Tappy L; Dussoix P; Iynedjian P; Henry S; Schneiter P; Zahnd G; Jéquier E; Philippe J
Diabetes; 1997 Feb; 46(2):204-8. PubMed ID: 9000695
[TBL] [Abstract][Full Text] [Related]
17. Genetic and clinical characteristics of Chinese children with Glucokinase-maturity-onset diabetes of the young (GCK-MODY).
Li X; Ting TH; Sheng H; Liang CL; Shao Y; Jiang M; Xu A; Lin Y; Liu L
BMC Pediatr; 2018 Mar; 18(1):101. PubMed ID: 29510678
[TBL] [Abstract][Full Text] [Related]
18. Pregnancy in Women With Monogenic Diabetes due to Pathogenic Variants of the Glucokinase Gene: Lessons and Challenges.
Timsit J; Ciangura C; Dubois-Laforgue D; Saint-Martin C; Bellanne-Chantelot C
Front Endocrinol (Lausanne); 2021; 12():802423. PubMed ID: 35069449
[TBL] [Abstract][Full Text] [Related]
19. GCK gene mutations are a common cause of childhood-onset MODY (maturity-onset diabetes of the young) in Turkey.
Haliloglu B; Hysenaj G; Atay Z; Guran T; Abalı S; Turan S; Bereket A; Ellard S
Clin Endocrinol (Oxf); 2016 Sep; 85(3):393-9. PubMed ID: 27256595
[TBL] [Abstract][Full Text] [Related]
20. A novel glucokinase gene mutation and its effect on glycemic/C-peptide fluctuations in a patient with maturity-onset diabetes of the young type 2.
Loomba-Albrecht LA; Jame M; Bremer AA
Diabetes Res Clin Pract; 2010 Mar; 87(3):e23-5. PubMed ID: 20015564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
